Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Coagulation factor X | ||
Ligand | BDBM50112503 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEBML_49302 | ||
Ki | 0.080000±n/a nM | ||
Citation | Wu, S; Guilford, WJ; Chou, YL; Griedel, BD; Liang, A; Sakata, S; Shaw, KJ; Trinh, L; Xu, W; Zhao, Z; Morrissey, MM Design and synthesis of aminophenol-based factor Xa inhibitors. Bioorg Med Chem Lett12:1307-10 (2002) [PubMed] | ||
More Info.: | Get all data from this article, Assay Method | ||
Coagulation factor X | |||
Name: | Coagulation factor X | ||
Synonyms: | Activated coagulation factor X (FXa) | Activated factor Xa heavy chain | Coagulation factor X precursor | Coagulation factor Xa | F10 | FA10_HUMAN | Factor X heavy chain | Factor X light chain | Factor Xa | Stuart factor | Stuart-Prower factor | ||
Type: | Enzyme | ||
Mol. Mass.: | 54726.60 | ||
Organism: | Homo sapiens (Human) | ||
Description: | n/a | ||
Residue: | 488 | ||
Sequence: |
| ||
BDBM50112503 | |||
n/a | |||
Name | BDBM50112503 | ||
Synonyms: | 7-({4-[1-(1-Imino-ethyl)-piperidin-4-yloxy]-3-nitro-phenylamino}-methyl)-naphthalene-2-carboxamidine | CHEMBL25034 | ||
Type | Small organic molecule | ||
Emp. Form. | C25H28N6O3 | ||
Mol. Mass. | 460.5282 | ||
SMILES | CC([NH-])=[N+]1CCC(CC1)Oc1ccc(NCc2ccc3ccc(cc3c2)C(N)=N)cc1[N+]([O-])=O |(-2.07,-4.18,;-.74,-4.97,;-.74,-6.51,;.59,-4.2,;.61,-2.66,;1.94,-1.9,;3.27,-2.68,;3.27,-4.21,;1.94,-4.98,;4.6,-1.91,;5.93,-2.68,;5.93,-4.22,;7.26,-4.99,;8.61,-4.22,;9.95,-4.99,;9.95,-6.53,;11.28,-7.29,;11.28,-8.83,;12.61,-9.6,;13.94,-8.83,;15.28,-9.59,;16.62,-8.8,;16.6,-7.26,;15.27,-6.49,;13.94,-7.28,;12.61,-6.52,;17.93,-6.47,;17.92,-4.93,;19.27,-7.24,;8.61,-2.67,;7.26,-1.9,;7.26,-.36,;8.59,.41,;5.93,.4,)| | ||
Structure |